A stability-difference-selective bond-breakage strategy for the fabrication of largepore-sized hollow mesoporous organosilica nanoparticles (HMONs) is successfully developed. Moreover, surfacefunctionalized HMONs are successfully constructed to simultaneously deliver P-gp modulator siRNA and anticancer drug doxorubicin to reverse the multidrug resistance of cancer cells.
Keywords: cancer therapy; gene delivery; large pores; multidrug resistance; nanoparticles.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.